Antihypertensive therapy to maximally reduce coronary risk

Norman M Kaplan

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Antihypertensive therapy as it is currently prescribed has not provided the degree of protection against coronary disease that was predicted by epidemiologic evidence. At least five steps can be taken to maximally reduce coronary risk: (1) more frequent, out-of-the-office monitoring of blood pressure, particularly during the early morning hours; (2) diligent search for other coexisting coronary risk factors; (3) vigorous use of various life-style modifications; (4) greater selectivity in the choice of antihypertensive agents, using those that may provide additional benefits for other coronary risk factors and other coexisting conditions; and (5) avoidance of coronary hypoperfusion by too great a reduction of blood pressure.

Original languageEnglish (US)
Pages (from-to)1487-1493
Number of pages7
JournalAmerican Heart Journal
Volume125
Issue number5 PART 2
DOIs
StatePublished - 1993

Fingerprint

Antihypertensive Agents
Blood Pressure
Coronary Disease
Life Style
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Antihypertensive therapy to maximally reduce coronary risk. / Kaplan, Norman M.

In: American Heart Journal, Vol. 125, No. 5 PART 2, 1993, p. 1487-1493.

Research output: Contribution to journalArticle

Kaplan, Norman M. / Antihypertensive therapy to maximally reduce coronary risk. In: American Heart Journal. 1993 ; Vol. 125, No. 5 PART 2. pp. 1487-1493.
@article{c592951cb42542f1a425427f1e4666a7,
title = "Antihypertensive therapy to maximally reduce coronary risk",
abstract = "Antihypertensive therapy as it is currently prescribed has not provided the degree of protection against coronary disease that was predicted by epidemiologic evidence. At least five steps can be taken to maximally reduce coronary risk: (1) more frequent, out-of-the-office monitoring of blood pressure, particularly during the early morning hours; (2) diligent search for other coexisting coronary risk factors; (3) vigorous use of various life-style modifications; (4) greater selectivity in the choice of antihypertensive agents, using those that may provide additional benefits for other coronary risk factors and other coexisting conditions; and (5) avoidance of coronary hypoperfusion by too great a reduction of blood pressure.",
author = "Kaplan, {Norman M}",
year = "1993",
doi = "10.1016/0002-8703(93)90445-F",
language = "English (US)",
volume = "125",
pages = "1487--1493",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "5 PART 2",

}

TY - JOUR

T1 - Antihypertensive therapy to maximally reduce coronary risk

AU - Kaplan, Norman M

PY - 1993

Y1 - 1993

N2 - Antihypertensive therapy as it is currently prescribed has not provided the degree of protection against coronary disease that was predicted by epidemiologic evidence. At least five steps can be taken to maximally reduce coronary risk: (1) more frequent, out-of-the-office monitoring of blood pressure, particularly during the early morning hours; (2) diligent search for other coexisting coronary risk factors; (3) vigorous use of various life-style modifications; (4) greater selectivity in the choice of antihypertensive agents, using those that may provide additional benefits for other coronary risk factors and other coexisting conditions; and (5) avoidance of coronary hypoperfusion by too great a reduction of blood pressure.

AB - Antihypertensive therapy as it is currently prescribed has not provided the degree of protection against coronary disease that was predicted by epidemiologic evidence. At least five steps can be taken to maximally reduce coronary risk: (1) more frequent, out-of-the-office monitoring of blood pressure, particularly during the early morning hours; (2) diligent search for other coexisting coronary risk factors; (3) vigorous use of various life-style modifications; (4) greater selectivity in the choice of antihypertensive agents, using those that may provide additional benefits for other coronary risk factors and other coexisting conditions; and (5) avoidance of coronary hypoperfusion by too great a reduction of blood pressure.

UR - http://www.scopus.com/inward/record.url?scp=0027155727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027155727&partnerID=8YFLogxK

U2 - 10.1016/0002-8703(93)90445-F

DO - 10.1016/0002-8703(93)90445-F

M3 - Article

C2 - 8480619

AN - SCOPUS:0027155727

VL - 125

SP - 1487

EP - 1493

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 5 PART 2

ER -